Skip to main content
Clinical Trials/NCT04788537
NCT04788537
Completed
N/A

Services to Enhance Social Functioning in Adults With Autism Spectrum Disorders

University of Pennsylvania1 site in 1 country44 target enrollmentFebruary 16, 2021

Overview

Phase
N/A
Intervention
Not specified
Conditions
Autism
Sponsor
University of Pennsylvania
Enrollment
44
Locations
1
Primary Endpoint
Reduction in Social Responsiveness Scale, Second Edition (SRS-2) - Adult (Relative/Other Report)
Status
Completed
Last Updated
last year

Overview

Brief Summary

The purpose of this study is to test a novel, three-part cognitive behavioral treatment strategy to improve social functioning in adults with autism spectrum disorder.

The treatment, named TUNE In (Training to Understand and Navigate Emotions and Interactions), includes components to address the many behavioral domains involved in social functioning, including social motivation, social anxiety, social cognition, social skills, and generalization of the skills to community settings.

The Investigators will test the efficacy of TUNE In to improve social functioning in adults with autism spectrum disorder (ASD), using a randomized controlled trial using the SRS-2 as the primary outcome measure.

Registry
clinicaltrials.gov
Start Date
February 16, 2021
End Date
June 22, 2023
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • diagnosis of autism spectrum disorder

Exclusion Criteria

  • intellectual disability
  • severe mood or psychotic symptoms experienced in the past 4 weeks
  • severe self-injurious or aggressive behavior
  • severe extrapyramidal motor or sedating side effects of medications
  • concomitant participation in another social skills treatment program.

Outcomes

Primary Outcomes

Reduction in Social Responsiveness Scale, Second Edition (SRS-2) - Adult (Relative/Other Report)

Time Frame: Baseline and Post-Treatment (~1 year after baseline)

Scale ranges from 30 to 90 with higher T-scores indicating greater severity of autism symptomatology.

Study Sites (1)

Loading locations...

Similar Trials